{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:34:12Z","timestamp":1782869652880,"version":"3.54.5"},"reference-count":33,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T00:00:00Z","timestamp":1364256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Numerous studies have evaluated the prevalence and importance of vitamin D deficiency among patients with chronic kidney disease and end\u2010stage renal disease; however, little is known about vitamin D levels in acute kidney injury (<jats:styled-content style=\"fixed-case\">AKI<\/jats:styled-content>). We evaluated the association between vitamin D metabolites and clinical outcomes among patients with <jats:styled-content style=\"fixed-case\">AKI<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Prospective cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>A total of 30 participants with <jats:styled-content style=\"fixed-case\">AKI<\/jats:styled-content> and 30 controls from general hospital wards and intensive care units at a tertiary care hospital were recruited for the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements<\/jats:title><jats:p>Plasma levels of 25\u2010hydroxyvitamin D [25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)D], 1,25\u2010dihydroxyvitamin D [1,25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)<jats:sub>2<\/jats:sub>D], 24R,25\u2010dihydroxyvitamin D<jats:sub>3<\/jats:sub>, vitamin D binding protein (<jats:styled-content style=\"fixed-case\">VDBP<\/jats:styled-content>) and fibroblast growth factor 23 (<jats:styled-content style=\"fixed-case\">FGF<\/jats:styled-content>23) were measured within 24 hours of <jats:styled-content style=\"fixed-case\">AKI<\/jats:styled-content> onset and 5 days later. Bioavailable 25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)D and 1,25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)<jats:sub>2<\/jats:sub>D levels, defined as the sum of free\u2010 and albumin\u2010bound 25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)D and 1,25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)<jats:sub>2<\/jats:sub>D, were estimated using equations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to controls, participants with <jats:styled-content style=\"fixed-case\">AKI<\/jats:styled-content> had lower levels of 1,25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)<jats:sub>2<\/jats:sub>D [17 (10\u201322) <jats:italic>vs<\/jats:italic> 25 (15\u201335) pg\/ml, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b701], lower levels of <jats:styled-content style=\"fixed-case\">VDBP<\/jats:styled-content> [23 (15\u201031) <jats:italic>vs<\/jats:italic> 29 (25\u201336) mg\/dl, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7003] and similar levels of bioavailable 25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)D and 1,25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)<jats:sub>2<\/jats:sub>D at enrolment. Levels of bioavailable 25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)D were inversely associated with severity of sepsis in the overall sample (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001). Among participants with <jats:styled-content style=\"fixed-case\">AKI<\/jats:styled-content>, bioavailable 25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)D, but not other vitamin D metabolites, was significantly associated with mortality after adjusting for age and serum creatinine (adjusted odds ratio per 1 <jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content> ln [bioavailable 25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)D]\u00a0=\u00a00\u00b716, 95% confidence interval\u00a0=\u00a00\u00b703\u20130\u00b785).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Bioavailable 25(<jats:styled-content style=\"fixed-case\">OH<\/jats:styled-content>)D could have a role as a biomarker or mediator of adverse outcomes among patients with established <jats:styled-content style=\"fixed-case\">AKI<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cen.12172","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:28:02Z","timestamp":1361233682000},"page":"491-498","source":"Crossref","is-referenced-by-count":65,"title":["Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes"],"prefix":"10.1111","volume":"79","author":[{"given":"David E.","family":"Leaf","sequence":"first","affiliation":[{"name":"Division of Nephrology Columbia University Medical Center New York NY USA"},{"name":"Division of Renal Medicine Brigham and Women's Hospital Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushrut S.","family":"Waikar","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine Brigham and Women's Hospital Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension University of Miami Miller School of Medicine Miami FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Cremers","sequence":"additional","affiliation":[{"name":"Division of Endocrinology Columbia University Medical Center New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishir","family":"Bhan","sequence":"additional","affiliation":[{"name":"Division of Nephrology Massachusetts General Hospital Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Stern","sequence":"additional","affiliation":[{"name":"Division of Nephrology Columbia University Medical Center New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06040710"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.551"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000098645"},{"key":"e_1_2_7_5_1","first-page":"267","article-title":"Assessment of immune status in relation to vitamin D levels in children on regular hemodialysis","volume":"23","author":"Youssef D.M.","year":"2012","journal-title":"Saudi Journal of Kidney Diseases and Transplantation"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.086"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2006.11.009"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1988.30"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2003.64.1161"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000057374"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000187175"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2011.07.021"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318206ccdf"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcs014"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31822d74f3"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc5713"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000050454.01978.3B"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-63-4-954"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.387"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.19"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00550112"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.313"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20041799"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm778"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2010.10.007"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210118"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/138.2.429"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2378"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1123933"},{"issue":"1302","key":"e_1_2_7_30_1","first-page":"e1","article-title":"Circulating levels of 25\u2010hydroxyvitamin D and human cathelicidin in healthy adults","volume":"127","author":"Bhan I.","year":"2011","journal-title":"journal of Allergy and Clinical Immunology in Practice"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-7-28"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1086\/596314"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030358"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-11-149"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.12172","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.12172","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cen.12172","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.12172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T17:47:18Z","timestamp":1696355238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.12172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1111\/cen.12172"],"URL":"https:\/\/doi.org\/10.1111\/cen.12172","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,26]]}}}